Aaron Rodriguez+FollowDog Cancer Breakthroughs You Need to KnowDid you know 1 in 4 dogs will face cancer? But there’s real hope: researchers are making huge strides, and some treatments for dogs could even help humans. From new blood tests that catch cancer early to personalized immunotherapy for bone cancer, the fight is getting smarter. Plus, there’s a new PBS doc featuring pups in clinical trials—total tearjerker but super inspiring. If you’ve got a senior or high-risk breed, regular vet checks are a must! #DogHealth #PetCancer #VetMedicine #DogLovers #CancerResearch #Health20Share
Charles Christensen+FollowHER3: The Comeback Kid in Cancer ResearchTurns out HER3, once thought to be a benchwarmer in cancer, is actually a major player! Scientists now say HER3 helps tumors survive and resist treatment, especially in breast and lung cancers. The catch? Not all patients benefit from HER3-targeted drugs—only those with active HER3 signaling. New antibody-drug combos are showing promise, but matching the right patients is key. HER3 might finally get its moment as a precision cancer therapy superstar! #CancerResearch #HER3 #PrecisionMedicine #Oncology #MedicalBreakthrough #Health01Share
Jacqueline Howard DDS+FollowAstraZeneca’s Cancer Drug Scores Big!AstraZeneca just dropped some major news—its cancer drug Imfinzi, when paired with standard therapy, helped high-risk bladder cancer patients stay cancer-free longer! No new safety issues popped up, and patients could stick with their treatments. Imfinzi’s already a big deal for other cancers, but this new data could mean even more approvals. No wonder AZN stock is getting a little love today! Anyone else watching this stock now? #AstraZeneca #Imfinzi #CancerResearch #Biotech #StockMarket #Health252Share
john24+FollowHoliday Hangover or Hidden Danger?Ever brushed off feeling weird on holiday as just too much sun or food? Wayne did, but it turned out to be the first sign of a brain tumour. He ignored fatigue, mood swings, and blurry vision, thinking it was just ageing—until a stroke forced him to hospital, where doctors finally found the tumour. Now he’s raising awareness (and funds!) for brain tumour research. Don’t ignore those odd symptoms—sometimes it’s more than just a rough day! #BrainTumourAwareness #HealthMatters #ListenToYourBody #CancerResearch #Health10Share
Sarah Bennett+FollowBrexit’s Messy Side: Cancer Trials Hit HardBrexit isn’t just about politics—it’s slowing down cancer research in the UK! Since leaving the EU, researchers are dealing with delayed clinical trials, drug import headaches, and even destroyed samples. Cancer Research UK says 80% of scientists are struggling to collaborate with EU partners, and costs are up across the board. Their fix? Less red tape, smoother trade, and better data sharing with Europe. It’s wild how much this impacts real lives and breakthroughs! #BrexitImpact #CancerResearch #ScienceMatters #ClinicalTrials #UKNews #Health00Share
Jacqueline Howard DDS+FollowDNA Methylation Is Changing Brain Tumor CareDid you know DNA methylation profiling is totally shaking up how doctors diagnose and treat brain and spinal cord tumors? It’s not just for research anymore—this tech is now part of real-world clinical guidelines! Experts like Dr. Matija Snuderl are leading the charge, and the latest WHO updates are embracing these advances. Curious how this all happened and what’s next for CNS tumor care? The future of brain tumor diagnosis is here, and it’s wild! #BrainTumor #MedicalInnovation #DNAMethylation #CancerResearch #HealthTech #Health00Share
Ryan Lewis+FollowIs This Cheap Pill a Cancer Game-Changer?Metformin, the diabetes med your grandma might already take, is being studied as a possible secret weapon against colon cancer. Early research shows it could help fight tough-to-treat cancer cells, especially the kind linked to a tricky KRAS gene. It’s not a cure on its own, but as a supplement to other treatments? Super promising. Plus, it’s dirt cheap—just 20 cents a pill! Scientists are hyped, but more tests are needed before it hits the mainstream. Imagine if this old-school drug gets a new life! #HealthNews #CancerResearch #Metformin #MedicalBreakthrough #ColonCancer #Health505Share
Ryan Lewis+FollowSkipping Cancer Surgery? This Is HugeDid you see this? A new study found that some people with early-stage cancers (like rectal or colon) might be able to ditch surgery altogether and just use immunotherapy. 82% of patients on Jemperli had no signs of cancer after 6 months—most skipped surgery and kept their organs! It works best for tumors with a thing called dMMR, so if you or someone you know is dealing with this, ask the doc about it. Imagine beating cancer without going under the knife! #CancerResearch #Immunotherapy #MedicalBreakthrough #Jemperli #HealthNews #Health180Share
Aaron Rodriguez+FollowBioNTech’s Big Cancer Drug MoveBioNTech is making waves again—this time, they’re prepping to file for approval of their first cancer drug, BNT323, by the end of 2024. But with all the tariff drama and global supply chain jitters, they’re not taking any chances: BioNTech’s diversifying its suppliers so they’re not just relying on China. Plus, they’re sitting on a massive cash pile from their COVID-19 vaccine days, fueling even more cancer research. New CFO incoming, too! #BioNTech #CancerResearch #PharmaNews #DrugApproval #Biotech #Health110Share
Jacqueline Howard DDS+FollowGame-Changer for Aggressive Colon CancerBig news for folks battling BRAF V600E-mutated metastatic colorectal cancer: the FDA just approved a new combo—Braftovi + Erbitux + chemo—as a first-line treatment! The BREAKWATER trial showed this mix bumps response rates up to 60% (vs. 40% with chemo alone). Translation: more patients are seeing their tumors shrink and feeling better, faster. If you or someone you know is dealing with this tough cancer, this could be a real lifeline. Testing for the BRAF mutation early is now more important than ever! #CancerResearch #FDAApproval #ColorectalCancer #BRAFMutation #MedicalBreakthrough #Health411Share
